TenNor Therapeutics (Suzhou) Limited (HKG:6872)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
202.00
-1.60 (-0.79%)
Jun 1, 2026, 4:08 PM HKT

HKG:6872 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Net Income
-153.24-145.93-191.84
Depreciation & Amortization
1.462.592.8
Other Amortization
0.120.10.09
Loss (Gain) From Sale of Assets
0-0.02-0.04
Loss (Gain) From Sale of Investments
-0.49-0.01-0.72
Stock-Based Compensation
36.848.69.82
Other Operating Activities
35.968.1668.9
Change in Accounts Payable
-8.01-6.9713.95
Change in Other Net Operating Assets
0.2224.87-1.07
Operating Cash Flow
-87.2-48.6-98.12
Capital Expenditures
-0.23-0.2-0.4
Sale of Property, Plant & Equipment
-0.01-
Cash Acquisitions
0.38--
Sale (Purchase) of Intangibles
-0.23--0.12
Investment in Securities
--70
Other Investing Activities
2.580.010.89
Investing Cash Flow
2.5-0.1970.38
Long-Term Debt Issued
32.54930
Long-Term Debt Repaid
-59.42-55.09-27.78
Net Debt Issued (Repaid)
-26.92-6.092.22
Issuance of Common Stock
203.6298.314.86
Other Financing Activities
-6.07-3.72-2.36
Financing Cash Flow
170.6488.54.73
Foreign Exchange Rate Adjustments
0.01-0.01-0.01
Net Cash Flow
85.9539.71-23.02
Free Cash Flow
-87.42-48.8-98.51
Free Cash Flow Per Share
-2.19-1.30-2.67
Cash Interest Paid
1.511.92.36
Levered Free Cash Flow
-42.78-811.56-
Unlevered Free Cash Flow
-41.85-810.38-
Change in Working Capital
-7.7917.912.88